Filtros de búsqueda

Lista de obras de Carlos Taxonera

2019 Novel Coronavirus Disease (COVID-19) in patients with Inflammatory Bowel Diseases

artículo científico publicado en 2020

Adalimumab Maintenance Treatment in Ulcerative Colitis: Outcomes by Prior Anti-TNF Use and Efficacy of Dose Escalation.

artículo científico publicado en 2016

Adalimumab for Induction of Histological Remission in Moderately to Severely Active Ulcerative Colitis.

artículo científico publicado en 2018

Adalimumab reversed a severe lymphopenia in a patient with Crohn's disease ⬇️

artículo científico publicado el 14 de diciembre de 2011

Analysis of a non-synonymous single nucleotide polymorphism of the human diamine oxidase gene (ref. SNP ID: rs1049793) in patients with Crohn's disease

article

Diagnostic Performance of the Simple Clinical Colitis Activity Index Self-Administered Online at Home by Patients With Ulcerative Colitis: CRONICA-UC Study.

artículo científico publicado en 2016

Differences in the need for adalimumab dose optimization between Crohn's disease and ulcerative colitis

artículo científico publicado en 2019

Early dose optimization of golimumab induces late response and long-term clinical benefit in moderately to severely active ulcerative colitis

artículo científico publicado en 2019

Editorial: social distancing during the COVID-19 pandemic-IBD patients cannot stay at home forever. Authors' reply

scientific article published on 01 August 2020

Effectiveness of anti-TNFα drugs in patients with Crohn's disease who do not achieve remission with their first anti-TNFα agent.

artículo científico publicado en 2016

Endoscopic follow-up and therapeutic attitude after ileocolonic resection in a nationwide Spanish cohort of Crohn's disease patients: the Practicrohn study

scientific article published on 17 June 2019

Erratum: Corrigendum: Diagnostic Performance of the Simple Clinical Colitis Activity Index Self-Administered Online at Home by Patients With Ulcerative Colitis: CRONICA-UC Study

artículo científico publicado en 2016

Fecal calprotectin and lactoferrin for the prediction of inflammatory bowel disease relapse

artículo científico publicado en 2009

Functional rare variants influence the clinical response to anti-TNF therapy in Crohn's disease

artículo científico publicado en 2019

GSTT1 and GSTM1 null genotypes may facilitate hepatitis C virus infection becoming chronic

artículo científico publicado en 2007

Genetic predisposition to acute gastrointestinal bleeding after NSAIDs use

artículo científico publicado en 2004

Interaction of CYP2C8 and CYP2C9 genotypes modifies the risk for nonsteroidal anti-inflammatory drugs-related acute gastrointestinal bleeding

artículo científico publicado en 2008

Letter: SARS-CoV-2 induced gastrointestinal inflammation-authors' reply

artículo científico publicado en 2020

Letter: immunotherapy for IBD patients in a SARS-CoV-2 endemic area-authors' reply

scientific article published on 01 September 2020

Letter: intestinal inflammation, COVID-19 and gastrointestinal ACE2-exploring RAS inhibitors-authors' reply

artículo científico publicado en 2020

Letter: severe COVID-19 infection and biologic therapies-a cohort study of 7808 patients in France. Authors' reply

artículo científico publicado en 2020

Methotrexate in inflammatory bowel disease

artículo científico publicado en 2012

Mucosal healing for predicting clinical outcome in patients with ulcerative colitis using thiopurines in monotherapy ⬇️

artículo científico publicado el 27 de julio de 2011

Recurrent granulomatous cheilitis associated with Crohn's disease successfully treated with ustekinumab: case report and literature review

artículo científico publicado en 2020

Reliability evaluation of four different assays for therapeutic drug monitoring of infliximab levels

scientific article published on 26 June 2018

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda